Viewing Study NCT00943592


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-28 @ 9:49 AM
Study NCT ID: NCT00943592
Status: COMPLETED
Last Update Posted: 2014-02-27
First Post: 2009-07-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clofarabine-Melphalan-Alemtuzumab Conditioning in Patients With Advanced Hematologic Malignancies
Sponsor: University of Chicago
Organization: